Skip to main content

Legacy Advisors, LLC

SEC CIK
0001720969
Latest filing
Jul 24, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Legacy Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
16,549
Value
$4.16M
% of portfolio
0.4%
Quarters held
21
Since Q1 2021
Holdings of ABBV by Legacy Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202616,549$4.16M0.4%+1,322+8.7%AddedHolders
Q1 202615,227$3.31M0.4%−425−2.7%ReducedHolders
Q4 202515,652$3.58M0.4%+951+6.5%AddedHolders
Q3 202514,701$3.40M0.4%+14,701NewHolders
Q2 20250$00.0%−21,983−100.0%Sold outHolders
Q1 202521,983$4.61M0.5%+1,171+5.6%AddedHolders
Q4 202420,812$3.70M0.4%−1,085−5.0%ReducedHolders
Q3 202421,897$4.32M0.5%+2,025+10.2%AddedHolders
Q2 202419,872$3.41M0.4%+52+0.3%AddedHolders
Q1 202419,820$3.61M0.5%+769+4.0%AddedHolders
Q4 202319,051$2.95M0.4%−1,753−8.4%ReducedHolders
Q3 202320,804$3.10M0.5%+3,382+19.4%AddedHolders
Q2 202317,422$2.35M0.3%+12,244+236.5%AddedHolders
Q1 20235,178$825.2K0.2%+184+3.7%AddedHolders
Q4 20224,994$807.1K0.1%+214+4.5%AddedHolders
Q3 20224,780$642.0K0.1%−278−5.5%ReducedHolders
Q2 20225,058$775.0K0.2%+271+5.7%AddedHolders
Q1 20224,787$776.0K0.2%+2,818+143.1%AddedHolders
Q4 20211,969$267.0K0.1%−195−9.0%ReducedHolders
Q3 20212,164$233.0K0.1%+206+10.5%AddedHolders
Q2 20211,958$221.0K0.1%00.0%UnchangedHolders
Q1 20211,958$212.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.